Beijer Alma AB (publ) (FRA:6O4)

Intra-Cellular Therapies Revenue

Beijer Alma AB had revenue of 2.02B SEK in the quarter ending June 30, 2025, with 7.32% growth. This brings the company's revenue in the last twelve months to 7.49B, up 5.99% year-over-year. In the year 2024, Beijer Alma AB had annual revenue of 7.20B with 4.66% growth.

• Revenue (ttm): 7.49B SEK
• Revenue Growth: +5.99%
• P/S Ratio: 2.08
• Revenue / Employee: 2.63M SEK
• Employees: 2,848
• Market Cap: 1.40B USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.20B	321.00M	4.66%
Dec 31, 2023	6.88B	1.02B	17.32%
Dec 31, 2022	5.87B	1.29B	28.08%
Dec 31, 2021	4.58B	330.10M	7.77%
Dec 31, 2020	4.25B	-371.93M	-8.05%